These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 19596256)

  • 1. Gain of chromosome arm 1q in patients in relapse and progression of multiple myeloma.
    Balcárková J; Urbánková H; Scudla V; Holzerová M; Bacovský J; Indrák K; Jarosová M
    Cancer Genet Cytogenet; 2009 Jul; 192(2):68-72. PubMed ID: 19596256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic instability in multiple myeloma: evidence for jumping segmental duplications of chromosome arm 1q.
    Sawyer JR; Tricot G; Lukacs JL; Binz RL; Tian E; Barlogie B; Shaughnessy J
    Genes Chromosomes Cancer; 2005 Jan; 42(1):95-106. PubMed ID: 15472896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Correlation between chromosome 13q14 deletion and 1q abnormality in multiple myeloma].
    Chen LJ; Li JY; Zhu Y; Wang XW; Qiu HR; Yang RF; Xu W; Xu JR; Lu H
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Feb; 26(1):102-5. PubMed ID: 19199264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of chromosome numerical changes in multiple myeloma: fluorescence in situ hybridization analysis using 15 chromosome-specific probes.
    Tabernero D; San Miguel JF; Garcia-Sanz M; Nájera L; García-Isidoro M; Peréz-Simon JA; Gonzalez M; Wiegant J; Raap AK; Orfão A
    Am J Pathol; 1996 Jul; 149(1):153-61. PubMed ID: 8686739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromosome 1 abnormalities in multiple myeloma.
    Marzin Y; Jamet D; Douet-Guilbert N; Morel F; Le Bris MJ; Morice P; Abgrall JF; Berthou C; De Braekeleer M
    Anticancer Res; 2006; 26(2A):953-9. PubMed ID: 16619492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormalities of chromosome 1p/q are highly associated with chromosome 13/13q deletions and are an adverse prognostic factor for the outcome of high-dose chemotherapy in patients with multiple myeloma.
    Wu KL; Beverloo B; Lokhorst HM; Segeren CM; van der Holt B; Steijaert MM; Westveer PH; Poddighe PJ; Verhoef GE; Sonneveld P; ;
    Br J Haematol; 2007 Feb; 136(4):615-23. PubMed ID: 17223915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pattern of trisomy 1q in hematological malignancies: a single institution experience.
    Djordjević V; Dencić-Fekete M; Jovanović J; Drakulić D; Stevanović M; Janković G; Gotić M
    Cancer Genet Cytogenet; 2008 Oct; 186(1):12-8. PubMed ID: 18786437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacterial artificial chromosome array-based comparative genomic hybridization using paired formalin-fixed, paraffin-embedded and fresh frozen tissue specimens in multiple myeloma.
    Lennon PA; Zhuang Y; Pierson D; Zhang X; Williams C; Perez C; Lin P
    Cancer; 2009 Jan; 115(2):345-54. PubMed ID: 19109814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gain of 1q21 is an unfavorable genetic prognostic factor for multiple myeloma patients treated with high-dose chemotherapy.
    Nemec P; Zemanova Z; Greslikova H; Michalova K; Filkova H; Tajtlova J; Kralova D; Kupska R; Smetana J; Krejci M; Pour L; Zahradova L; Sandecka V; Adam Z; Buchler T; Spicka I; Gregora E; Kuglik P; Hajek R
    Biol Blood Marrow Transplant; 2010 Apr; 16(4):548-54. PubMed ID: 20005965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrent involvement of heterochromatic regions in multiple myeloma-a multicolor FISH study.
    Lange K; Gadzicki D; Schlegelberger B; Göhring G
    Leuk Res; 2010 Aug; 34(8):1002-6. PubMed ID: 20022374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gain of 1q and loss of 9q21.3-q32 are associated with a less favorable prognosis in papillary thyroid carcinoma.
    Kjellman P; Lagercrantz S; Höög A; Wallin G; Larsson C; Zedenius J
    Genes Chromosomes Cancer; 2001 Sep; 32(1):43-9. PubMed ID: 11477660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic alterations of chromosome region 11p as predictive marker by array comparative genomic hybridization in lung adenocarcinoma patients.
    Sung JS; Park KH; Kim YH
    Cancer Genet Cytogenet; 2010 Apr; 198(1):27-34. PubMed ID: 20303011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progression in smoldering myeloma is independently determined by the chromosomal abnormalities del(17p), t(4;14), gain 1q, hyperdiploidy, and tumor load.
    Neben K; Jauch A; Hielscher T; Hillengass J; Lehners N; Seckinger A; Granzow M; Raab MS; Ho AD; Goldschmidt H; Hose D
    J Clin Oncol; 2013 Dec; 31(34):4325-32. PubMed ID: 24145347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative genomic hybridization of 49 primary retinoblastoma tumors identifies chromosomal regions associated with histopathology, progression, and patient outcome.
    Lillington DM; Kingston JE; Coen PG; Price E; Hungerford J; Domizio P; Young BD; Onadim Z
    Genes Chromosomes Cancer; 2003 Feb; 36(2):121-8. PubMed ID: 12508240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phyllodes tumors of the breast analyzed by comparative genomic hybridization and association of increased 1q copy number with stromal overgrowth and recurrence.
    Lu YJ; Birdsall S; Osin P; Gusterson B; Shipley J
    Genes Chromosomes Cancer; 1997 Nov; 20(3):275-81. PubMed ID: 9365835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Array-based comparative genomic hybridization of mapped BAC DNA clones to screen for chromosome 14 copy number abnormalities in meningiomas.
    Espinosa AB; Mackintosh C; Maíllo A; Gutierrez L; Sousa P; Merino M; Ortiz J; de Alava E; Orfao A; Tabernero MD
    Eur J Hum Genet; 2008 Dec; 16(12):1450-8. PubMed ID: 18628790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interphase fluorescence in situ hybridization in multiple myeloma and monoclonal gammopathy of undetermined significance without and with positive plasma cell identification: analysis of 192 cases from the Region of Southern Denmark.
    Christensen JH; Abildgaard N; Plesner T; Nibe A; Nielsen O; Sørensen AG; Kerndrup GB;
    Cancer Genet Cytogenet; 2007 Apr; 174(2):89-99. PubMed ID: 17452249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of ameloblastomas by comparative genomic hybridization and fluorescence in situ hybridization.
    Toida M; Balázs M; Treszl A; Rákosy Z; Kato K; Yamazaki Y; Matsui T; Suwa T; Hatakeyama D; Makita H; Mori S; Yamashita T; Shibata T; Adány R
    Cancer Genet Cytogenet; 2005 Jun; 159(2):99-104. PubMed ID: 15899380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative genomic hybridisation identifies two variants of smoldering multiple myeloma.
    Rosiñol L; Carrió A; Bladé J; Queralt R; Aymerich M; Cibeira MT; Esteve J; Rozman M; Campo E; Montserrat E
    Br J Haematol; 2005 Sep; 130(5):729-32. PubMed ID: 16115129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular cytogenetic analysis of genomic instability at the 1q12-22 chromosomal site in B-cell non-Hodgkin lymphoma.
    Itoyama T; Nanjungud G; Chen W; Dyomin VG; Teruya-Feldstein J; Jhanwar SC; Zelenetz AD; Chaganti RS
    Genes Chromosomes Cancer; 2002 Dec; 35(4):318-28. PubMed ID: 12378526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.